Kathy-Ann Secker

Inhibition of effector B cells by ibrutinib in systemic sclerosis

Jakob Einhaus, Ann‐Christin Pecher, Elisa Asteriti et al. · Arthritis Research & Therapy · 2020 · 42 citations · Full text

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9

Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr‐Stoerzer et al. · Oncogene · 2019 · 37 citations

Off-target Effect, Synergistic Anti-tumor Activity, Gene Editing +7

Chromobodies to Quantify Changes of Endogenous Protein Concentration in Living Cells

Bettina-Maria Keller, Julia Maier, Kathy-Ann Secker et al. · Molecular & Cellular Proteomics · 2018 · 35 citations · Full text

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis

Kathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler et al. · Cancers · 2020 · 31 citations · Full text

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations

Kathy-Ann Secker, Lukas Bruns, Hildegard Keppeler et al. · Cancers · 2020 · 26 citations · Full text